ImmunologybioRxivPreprint
Elevated HLA-E and NKG2A as a consequence of chronic immune activation defines resistance to M. bovis BCG immunotherapy in Non-Muscle-Invasive Bladder Cancer
D. Ranti, Y.-S. Wang, J. Daza…·A. Horowitz
The paper identifies elevated HLA-E and NKG2A as markers of resistance to BCG immunotherapy in NMIBC, linked to immune escape mechanisms.
DOI 10.1101/2022.03.06.483198